Hemangioendothelioma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Safety and Efficacy of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization
Conditions: Congenital Hemangioma; Hemangioendothelioma; Angiosarcoma; Arteriovenous MalformationIntervention: Procedure: selective transarterial catheterization using Lipiodol® Ultra Fluid in association with surgical gluesSponsor: GuerbetNot yet recruiting - verified December 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2015 Category: Research Source Type: clinical trials
Safety and Efficacy of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization
Conditions: Congenital Hemangioma; Hemangioendothelioma; Angiosarcoma; Arteriovenous MalformationIntervention: Procedure: selective transarterial catheterization using Lipiodol® Ultra Fluid with surgical gluesSponsor: GuerbetNot yet recruiting - verified December 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 3, 2015 Category: Research Source Type: clinical trials
Lymphatic Anomalies Registry
Conditions: Lymphatic Malformation; Generalized Lymphatic Anomaly (GLA); Central Conducting Lymphatic Anomaly; CLOVES Syndrome; Gorham-Stout Disease ("Disappearing Bone Disease"); Blue Rubber Bleb Nevus Syndrome; Kaposiform Lymphangiomatosis; Kaposiform Hemangioendothelioma/Tufted Angioma; Klippel-Trenaunay Syndrome; LymphangiomatosisIntervention: Sponsors: Children's Hospital Boston; Lymphatic Malformation InstituteRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 17, 2015 Category: Research Source Type: clinical trials
A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors
Conditions: Kaposiform Hemangioendothelioma (KHE); Kasabach-Merritt Syndrome; Tufted AngiomaInterventions: Drug: Vincristine; Drug: SirolimusSponsors: Children's Hospital Medical Center, Cincinnati; PfizerRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2014 Category: Research Source Type: clinical trials
A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors
Conditions: Kaposiform Hemangioendothelioma (KHE); Kasabach-Merritt Syndrome; Tufted AngiomaInterventions: Drug: Vincristine; Drug: SirolimusSponsors: Children's Hospital Medical Center, Cincinnati; PfizerNot yet recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2014 Category: Research Source Type: clinical trials
A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors
Conditions: Kaposiform Hemangioendothelioma (KHE); Kasabach-Merritt Syndrome; Tufted AngiomaInterventions: Drug: Vincristine; Drug: SirolimusSponsors: Children's Hospital Medical Center, Cincinnati; PfizerRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 8, 2014 Category: Research Source Type: clinical trials